English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduAn individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years, an international team of researchers has warned.
Tag: Diabetes
Van Andel Institute scientist awarded $2.9 million to tackle insulin resistance, a driver of Type 2 diabetes
Nick Burton, Ph.D., has earned a five-year, nearly $2.9 million New Innovator Award from the National Institutes of Health Common Fund to find new ways to fix or prevent insulin resistance, a key driver of Type 2 diabetes.
UCI launches innovative initiative to address diabetes in the Latinx community
Orange, Calif. — The University of California, Irvine has launched an initiative to address the toll diabetes takes on Orange County’s Latinx community and ensure greater well-being for a population that is disproportionately affected by the disease.
Pharmacist-led intervention can improve medication adherence among Latinos with type 2 diabetes
Diabetes control can significantly improve for Latinos when a pharmacist implements an intervention that addresses these patients’ barriers to medication adherence.
Wearable devices show who may need more help managing diabetes
A new Dartmouth study in the journal Science Advances suggests that how well people with diabetes manage their blood sugar depends on their experience with the condition and their overall success in controlling their glucose levels, as well as on the season and time of day.
Almost 4 in 10 adults with type 1 diabetes are not diagnosed until after age 30
A brief research report including more than 900 adults with type 1 diabetes found that 37 percent, or nearly 4 in 10 participants, were diagnosed with type 1 diabetes after age 30. Age of diagnosis was higher for men and racial minority adults. The findings are published in Annals of Internal Medicine.
Once-weekly insulin icodec with dosing guide app showed superior HbA1c reduction versus once-daily insulin in phase 3a trial
In the Phase 3a ONWARDS 5 randomized trial, once-weekly insulin icodec titrated with a dosing guide app demonstrated superior reduction in HbA1c levels and similarly low hypoglycemia rates compared with once-daily insulin. The findings are published in Annals of Internal Medicine.
Exercise-mimicking drug sheds weight, boosts muscle activity in mice
A new drug encourages weight loss and increases endurance by making the body act like it is exercising.
An implantable device could enable injection-free control of diabetes
One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin injections.
Self-reported “night owls” more likely to have unhealthy lifestyle behaviors, significantly increased diabetes risk
A study of more than 60,000 middle-aged nurses found that people with an evening chronotype, or a circadian preference to feel energetic later in the day, experienced an increased risk for diabetes and were more likely to report unhealthy lifestyle behaviors, such as smoking, poor sleep and physical inactivity, compared with persons with a morning chronotype.
COVID-19 and Type 1 Diabetes: Researchers Find an Increase in Islet Autoimmunity in Young Children Who Had a Sars-CoV-2 Infection
Type 1 diabetes is an autoimmune disease leading to an impaired glucose metabolism and requires life-long administration of insulin. While the cause of the autoimmunity reaction is still unclear, viral infections in young children are proposed to be critical environmental factors leading to type 1 diabetes.
MEDIA ADVISORY: Cedars-Sinai Experts Available to Discuss Safety, Benefits of Using Medications to Lose Weight
The science is unclear on exactly why an increasingly popular new class of federally approved diabetes and obesity medications work, but they do know that they are effective at helping people lose weight.
Endocrine Society honors endocrinology field’s leaders with 2024 Laureate Awards
The Endocrine Society today announced it has chosen 14 leading endocrinologists as winners of its prestigious 2024 Laureate Awards, the top honors in the field.
UC San Diego Health Nationally Recognized for Stroke and Diabetes Care
American Heart Association honors UC San Diego Health with multiple awards for its commitment to treating patients with heart disease and stroke.
Diabetes linked to functional and structural brain changes through MRI
A new study finds that the longer a person has type 2 diabetes, the more likely they may be to experience changes in brain structure. MRI results, researchers say, indicate the negative effects longstanding diabetes may have on brain health outcomes and emphasize the importance of preventing early onset type 2 diabetes.
Baylor Scott & White Health Again the Most-Awarded Health System in Texas for Clinical Care and Patient Experience
Baylor Scott & White Health once again leads the state of Texas in the number of accolades earned in U.S. News & World Report’s 2023-24 Best Hospitals, released today. A total of 26 Baylor Scott & White hospitals were recognized, including four facilities with a nationally ranked specialty – more than any other health system in Texas.
Baylor Scott & White Health Again the Most-Awarded Not-for-Profit Health System in Texas for Clinical Care and Patient Experience
Baylor Scott & White Health once again leads the state of Texas in the number of accolades earned in U.S. News & World Report’s 2023-24 Best Hospitals, released today. A total of 26 Baylor Scott & White hospitals were recognized, including four facilities with a nationally ranked specialty – more than any other health system in Texas.
UC San Diego Health Ranks No. 1 in San Diego, Makes National Honor Roll
U.S. News & World Report ranks 10 medical and surgical specialties at UC San Diego Health among the nation’s best.
Study looks at Achilles’ heel of insulin pump technology
A study of insulin pumps shows that repeated use sometimes results in pump sites becoming fibrotic, irritated and less effective at delivering insulin.
Is Snacking Bad for Your Health? It Depends on What and When You Eat
In a new study involving more than 1,000 people, researchers examined whether snacking affects health and if the quality of snack foods matters.
What is the Best Dieting Strategy for People with Type 2 Diabetes?
A new randomized controlled study of people with type 2 diabetes showed that study participants who restricted eating to between noon and 8 p.m. daily lost more weight than those who reduced their overall calorie intake by counting calories.
One pill doesn’t fit all: cholesterol study reveals effects on lung function and brain size
The first study in the world to compare cholesterol-lowering medications on a range of diseases has good and bad news for more than 200 million people.
NIH awards $3M to Wayne State to impact Black youth with type 1 diabetes
A Wayne State University School of Medicine professor has received a $3 million award from the National Institute on Minority Health and Health Disparities of the National Institutes of Health to develop an intervention aimed at improving health outcomes in Black youth with type 1 diabetes.
Neurons that track, regulate blood-sugar levels are found
Understanding how this blood-sugar detection system works and how these neurocircuits operate would give researchers and doctors greater insights into how our brains regulate our blood sugar and, perhaps, how to target them therapeutically to treat metabolic diseases like diabetes and obesity, according to the study authors.
Proteins Predict Significant Step Toward Development of Diabetes
Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.
Light or moderate alcohol consumption does not guard against diabetes, obesity
People who have just one or two drinks per day are not protected against endocrine conditions such as obesity and type 2 diabetes, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Nationwide Children’s Hospital Marks A Decade as One of the Nation’s Best
Nationwide Children’s Hospital has been named to U.S. News & World Report’s Best Children’s Hospitals Honor Roll for the 10th consecutive year. The Honor Roll is a top distinction awarded to only 10 children’s hospitals nationwide recognized by U.S. News as the “Best of the Best.” Nationwide Children’s is ranked sixth on the 2023-24 Honor Roll list.
CGM alarms often not set to alert children with diabetes to harmful blood glucose fluctuations
Children and teenagers who use continuous glucose monitors (CGM) to manage diabetes often fail to use the appropriate alarm settings to alert to dangerously low or harmful high blood sugar levels, according to a study being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill. This variability makes the monitors less useful in tracking glucose levels.
Duration and poor quality of sleep associated with greater risk for diabetes
Fewer than six hours or more than 10 hours of sleep, and poor quality of sleep are associated with a greater risk for diabetes, according to research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Early time-restricted feeding improves blood sugar levels
Early-time restricted feeding, a type of intermittent fasting, improved fluctuations in blood glucose levels and decreased time above range, according to research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Gestational diabetes cases increased during the COVID-19 pandemic
More pregnant women developed gestational diabetes during the COVID-19 pandemic than in the preceding two years, according to research being presented on Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Black patients with plaque build-up in arteries in the legs more likely to have a stroke, heart attack or amputation than white patients
A new study from Keck Medicine of USC has uncovered significant racial disparities in the diagnosis, treatment and outcomes of peripheral artery disease (PAD) among Black and white patients in the United States.
Even with insurance, many patients with diabetes turn to GoFundMe to offset high cost of care
An analysis of medical crowdfunding campaigns reveals the types of expenses that patients with diabetes may struggle to afford. The data showed that even insured patients with diabetes used GoFundMe to offset the excess costs of treatment beyond insulin, such as uncovered co-pays, indirect care, and alert dogs. The findings are published in Annals of Internal Medicine.
Blocking Signals from Receptor Involved in Fat Metabolism, Inflammation Improves Fatty Liver and Insulin Resistance in Mice
Article title: Inhibition of GPR120 signaling in intestine ameliorates insulin resistance and fatty liver under high-fat diet feeding Authors: Takuma Yasuda, Norio Harada, Tomonobu Hatoko, Atsuhiko Ichimura, Eri Ikeguchi-Ogura, Yuki Murata, Naoki Wada, Sakura Kiyobayashi, Shunsuke Yamane, Akira Hirasawa, Nobuya…
Sea cucumbers: the marine delicacy that can deter diabetes
They’re a marine delicacy loved across Asia, but the humble sea cucumber is also proving to be a key ingredient in preventing diabetes, according to new research from the University of South Australia.
High copayments for novel therapies may reduce patients’ medication adherence
UCLA-led study shows that patients with diabetes and heart failure who have high medication copayments for novel therapies have a significantly lower chance of consistently adhering to these medications.
New Penn Medicine Study Uncovers Key Details of Fat Cells, Advancing Potential Treatments for Obesity, Diabetes
New research has unlocked insights into how “good fat” tissue could potentially be harnessed to combat obesity and remove glucose from the blood, helping to control diabetes. Published today in Science Advances, the work is a collaboration between researchers with the Perelman School of Medicine at the University of Pennsylvania and University of Cambridge, Free University of Brussels and University of East Anglia.
ENDO 2023 press conferences to highlight emerging technology and diabetes research
Researchers will delve into the latest research in diabetes, obesity, reproductive health and other aspects of endocrinology during the Endocrine Society’s ENDO 2023 news conferences June 15-18.
A New Strategy to Break Through Bacterial Barriers in Chronic Treatment-Resistant Wounds
Researchers in UNC’s School of Medicine’s department of Microbiology and Immunology and the UNC-NC State Joint Department of Biomedical Engineering have developed a new strategy to improve drug-delivery into chronic wounds infections.
Vitamin K helps protect against diabetes
Canadian researchers have identified a new role for vitamin K and gamma-carboxylation in beta cells and their potentially protective role in diabetes, achieving a first in 15 years of basic research.
New study finds that Fitterfly Diabetes Digital Therapeutics Program Improves Blood Sugar Levels and Promotes Weight Loss in Patients With Type 2 Diabetes
Fitterfly’s diabetes digital therapeutics program shows real-world effectiveness in improving glycemic control and weight management among people with type 2 diabetes mellitus
Research to Prevent Blindness Announces New Sight-Saving Vision Research Grants
Research to Prevent Blindness (RPB) announces two new grants to support high-impact vision research. The new grants are the: RPB / Tom Wertheimer Career Development Award in Data Science and RPB / Mary Tyler Moore Vision Initiative Physician-Scientist Award.
Too Much Insulin Can Be as Dangerous as Too Little
UC San Diego researchers describe a key player in the defense mechanism that safeguards against excessive insulin in the body, which can be as harmful as too little.
nPOD honors Estefania Quesada Masachs for type 1 diabetes discoveries
La Jolla Institute for Immunology (LJI) Instructor Estefania Quesada Masachs, M.D., Ph.D., has won the 2023 Young Investigator of the Year Award from the Network for Pancreatic Organ donors with Diabetes (nPOD). This prestigious award recognizes Quesada Masachs’ groundbreaking research in type 1 diabetes.
Fasting diet reduces risk markers of type 2 diabetes
A fasting diet which focuses on eating early in the day could be the key to reducing the risk of developing type 2 diabetes, following the largest study in the world to date.
Diabetes Drug Improves Kidney Function and Inflammation
Article title: Reno-protective effects of empagliflozin are linked to activation of the tubuloglomerular feedback mechanism and blunting of the complement system Authors: Xin Chen, Denis Delić, Yaochen Cao, Linghong Shen, Qin Shao, Zheyu Zhang, Hongwei Wu, Ahmed A. Hasan, Christoph…
Prototype taps into the sensing capabilities of any smartphone to screen for prediabetes
Researchers at the University of Washington have developed GlucoScreen, a system that could enable people to self-screen for prediabetes.
University Hospitals Research Published in New England Journal of Medicine Shows Minimally Invasive Procedure Saves Most Patients with Severe Vascular Disease from Amputation
A study, co-led by University Hospitals Harrington Heart & Vascular Institute, could lead to the first FDA approval of a therapy giving thousands of patients hope for an alternative to amputation.
Bridging the Gap: addressing medical and social needs improves diabetes care and outcomes
Housed at the University of Chicago Medicine, the Bridging the Gap: Reducing Disparities in Diabetes Care Initiative has published the results of their five-year project aimed at addressing disparities in diabetes care nationwide.
A Registered Dietitian’s Reaction to the New FDA Proposed Rule on Salt
According to the American Heart Association, roughly 90% of Americans are overdoing it on salt, consuming over twice the daily recommended amount. The U.S. Food and Drug Administration (FDA) announced recently it was proposing a rule to allow the use of salt…